Segment Information (Tables)

3 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Segment Revenue, Operating (Loss) Income and Depreciation and Amortization

Segment revenue, operating (loss) income, and depreciation and amortization, were as follows:

	Three Months Ended
	December 31,
(Dollars in thousands)	2019			2018
Revenue:
Medical Device	$	17,404		$	17,258
In Vitro Diagnostics		5,212			4,983
Total revenue	$	22,616		$	22,241
Operating (loss) income:
Medical Device	$	(423	)	$	357
In Vitro Diagnostics		2,599			2,455
Total segment operating income		2,176			2,812
Corporate		(2,442	)		(2,100	)
Total operating (loss) income	$	(266	)	$	712
Depreciation and amortization:
Medical Device	$	1,455		$	1,388
In Vitro Diagnostics		110			116
Corporate		239			252
Total depreciation and amortization	$	1,804		$	1,756